Clinical trial
PROTECTED PCI STUDY: A Prospective Clinical Trial For Patients Undergoing Protected Percutaneous Coronary Intervention With IMPELLA® 2.5 System
NCT02831881 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROTECTED PCI STUDY: A Prospective Clinical Trial For Patients Undergoing Protected Percutaneous Coronary Intervention With IMPELLA® 2.5 System
- Lead sponsor
- Abiomed Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- Not reported
- Enrollment
- 369 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.